Morphological analysis of microparticle generation in heparin-induced thrombocyropenia

Blood

Volumn 96, Issue 1, 2000, Pages 188-194

  Hughes, Mary ^a   Hayward, Catherine P M ^a   Warkentin, Theodore E ^a   Horsewood, Peter ^a   Chorneyko, Katherine A ^a   Kelton, John G ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HEPARIN; MEMBRANE PROTEIN; SEROTONIN;

ANTIGEN EXPRESSION; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PARTICLE SIZE; PRIORITY JOURNAL; SEROTONIN RELEASE; SUCROSE DENSITY GRADIENT CENTRIFUGATION; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA; THROMBOSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0034235401     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.188.013k12_188_194     Document Type: Article

References (33)

1. Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia: diagnosis, natural history, and treatment options. Postgrad Med. 1998;103(suppl 2):169-171.
2. Warkentin TE, Kelton JG. Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H, ed. Low-Molecular-Weight Heparin in Prophylaxis and Therapy of Thromboembolic Diseases. New York, NY: Marcel Dekker; 1994:75.
3. Warkentin TE, Kelton JG. Heparin-induced thrombocytopenia. Prog Hemost Thromb. 1991;10:1-34.
4. Amiral J, Bridley F, Dreyfuss M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992;68:95-96.
5. Kelton JG, Smith JW, Warkentin TW, Hayward CPM, Denomme G, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood. 1994;83:3232-3239.
6. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 1994;93:81-88.
7. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion. 1994;34:381-385.
8. Greinacher A. Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994;71:247-251.
9. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67:27-30.
10. Kelton JG, Sheridan D, Santos A, et al. Heparin induced thrombocytopenia: laboratory studies. Blood. 1988;72:925-930.
11. Warkentin TE, Hayward CPM, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994;84(11): 3691-3699.
12. Warner MN, Pavord S, Moore JC, Warkentin TE, Hayward CP, Kelton JG. Serum-induced platelet procoagulant activity: an assay for the characterization of prothrombotic disorders. J Lab Clin Med. 1998;133:129-133.
13. Lee DH, Warkentin TE, Denomme GA, Hayward CP, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol. 1996;95:724-731.
14. Bode A, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood. 1991; 77:887-895.
15. Matzdorff AC, Kuhnel G, Kemkes-Matthes B, Pralle H. Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry. J Lab Clin Med. 1998;131: 507-517.
16. Ault KA. Platelet counting: is there room for improvement? Lab Hematol. 1996;2:139-141.
17. Lindahl TL, Restin R, Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation. Thromb Haemost. 1992;68:221-225.
18. George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet membrane microparticles from plasma and serum. Blood. 1982;60: 834-840.
19. Warkentin TE, Hayward CPM, Smith CM, Kelly PM, Kelton JG. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med. 1992;120: 371-379.
20. Horsewood P, Hayward CPM, Warkentin TE, Kelton JG. Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood. 1991;78:1019-1026.
21. Pasquet J-M, Dachary-Prigent J, Nurden AT. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem. 1996;239:647-654.
22. Pasquet J-M, Toti F, Nurden AT, Dachary-Prigent J. Procoagulant activity and active calpain in platelet-derived microparticles. Thromb Res. 1996;82:509-522.
23. Pidard D, Montgomery RR, Bennet JS, Kunicki TJ. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem. 1983;258:12582-12586.
24. George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet membrane microparticles from plasma and serum. Blood. 1982;60: 834-840.
25. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967; 13:269-288.
26. Reininger CB, Greinacher A, Graf J, Lasser R, Steckmeier B, Schweiberer L. Platelets of patients with peripheral arterial disease are hypersensitive to heparin. Thromb Res. 1996;81:641-649.
27. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry. 1990;29:623-632.
28. Yano Y, Kambayashi J-I, Shiba E, et al. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J. 1994;299:303-308.
29. Yano Y, Shiba E, Kambyashi J-I, et al. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane. Thromb Res. 1993; 71:385-396.
30. Lee YJ, Jy W, Horstmann LL, et al. Elevated microparticles in transient ischemic attacks, lacumar infarcts, and multi-infarct dementias. Thromb Res. 1993;72:295-304.
31. Miyamoto S, Marcinkiewicz C, Edmunds LH Jr, Niewiarowski S. Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/IIIa. Thromb Haemost. 1998;80:225-230.
32. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct activation of platelets and platelet-derived microparticles in humans. Blood. 1990;75:128-138.
33. Swords NA, Tracy PB, Mann KG. Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets. Arterioscler Thromb. 1993;13:1613-1622.